News

Pfizer: Building The Next Oncology Empire
Pfizer's $43B Seagen deal strengthens its oncology portfolio, offsets patent cliffs, and offers 70%+ upside potential. See ...
Cancer Pain 8 Major Market Forecast Report 2025-2034 | Opioids and Non-Opioids Drive Innovations, Medical Cannabis Emerges as Alternative
The cancer pain market, valued at USD 6.53 billion in 2024, is projected to reach USD 11.81 billion by 2034, with a CAGR of 6 ...